Oyster Therapeutics

Brain-penetrant targeted protein degraders

oyster-tx.com

Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.

About

London biotech, formerly Kesmalea Therapeutics, developing small oral targeted protein degraders via its SELFTAC platform, led by a tau degrader for Alzheimer's.

Location
London, UK
Added via
web
Ownership
unclaimed

Where to go